Search Results - Misty R. Jenkins

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy by Krishneel Prasad, Ryan S. Cross, Misty R. Jenkins

    Published in Molecular Oncology (2023-06-01)
    Get full text
    Article


  2. 2

    A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma by Kirti Pandey, Stacie S. Wang, Stacie S. Wang, Nicole A. Mifsud, Pouya Faridi, Pouya Faridi, Pouya Faridi, Pouya Faridi, Pouya Faridi, Alexander J. Davenport, Andrew I. Webb, Jarrod J. Sandow, Rochelle Ayala, Michelle Monje, Ryan S. Cross, Sri H. Ramarathinam, Misty R. Jenkins, Misty R. Jenkins, Misty R. Jenkins, Anthony W. Purcell

    Published in Frontiers in Oncology (2023-08-01)
    Get full text
    Article


  3. 3

    From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress by Brittany Dewdney, Misty R. Jenkins, Sarah A. Best, Saskia Freytag, Krishneel Prasad, Jeff Holst, Raelene Endersby, Terrance G. Johns

    Published in Signal Transduction and Targeted Therapy (2023-10-01)
    Get full text
    Article


  4. 4

    Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer by Zoe I. Day, Samuel Roberts-Thomson, Yasmin J. Nouri, Nathan S. Dalton, Stacie S. Wang, Alexander Davenport, Louise E. Ludlow, Mark D. Hulett, Ryan S. Cross, Misty R. Jenkins

    Published in npj Precision Oncology (2025-06-01)
    Get full text
    Article


  5. 5

    Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma by Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins

    Published in Clinical & Translational Immunology (2023-01-01)
    Get full text
    Article


  6. 6

    Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma by Stacie S. Wang, Kirti Pandey, Katherine A. Watson, Rebecca C. Abbott, Nicole A. Mifsud, Fiona M. Gracey, Sri H. Ramarathinam, Ryan S. Cross, Anthony W. Purcell, Misty R. Jenkins

    Published in Molecular Therapy: Oncolytics (2023-09-01)
    Get full text
    Article


  7. 7

    De novo-designed transmembrane domains tune engineered receptor functions by Assaf Elazar, Nicholas J Chandler, Ashleigh S Davey, Jonathan Y Weinstein, Julie V Nguyen, Raphael Trenker, Ryan S Cross, Misty R Jenkins, Melissa J Call, Matthew E Call, Sarel J Fleishman

    Published in eLife (2022-05-01)
    Get full text
    Article


  8. 8

    EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses by Katharine J Drummond, Jordan R Hansford, Misty R Jenkins, Lisa M Ebert, Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Alexander J Davenport, Raelene Endersby, Ryan Cross

    Published in Journal for ImmunoTherapy of Cancer (2024-08-01)
    Get full text
    Article


  9. 9

    PD-1 blockade enhances elotuzumab efficacy in mouse tumor models by Natalie A. Bezman, Amy Jhatakia, Alper Y. Kearney, Ty Brender, Mark Maurer, Karla Henning, Misty R. Jenkins, Amy J. Rogers, Paul J. Neeson, Alan J. Korman, Michael D. Robbins, Robert F. Graziano

    Published in Blood Advances (2017-05-01)
    Get full text
    Article


  10. 10

    Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma by Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes‐Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D’Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins

    Published in Clinical & Translational Immunology (2021-01-01)
    Get full text
    Article


  11. 11

    Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals by Palak H Mehta, Gemma S Trollope, Patrick Leung, Shivali Savita Chinni, Anna Iasinskaia, Aaron J Harrison, Hannah Hughes‐Parry, Misty R Jenkins, Michael H Kershaw, Anthony Jaworowski, Clare Y Slaney, Rachel M Koldej, David S Ritchie, Kylie M Quinn

    Published in Clinical & Translational Immunology (2024-01-01)
    Get full text
    Article


  12. 12

    The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells by Kelden Richardson, Simon P. Keam, Joe Jiang Zhu, Deborah Meyran, Criselle D’Souza, Sean Macdonald, Kerry Campbell, Michael Robbins, Natalie A. Bezman, Kirsten Todd, Hang Quach, David S. Ritchie, Simon J. Harrison, H. Miles Prince, Joseph A. Trapani, Misty R. Jenkins, Paul A. Beavis, Phillip K. Darcy, Paul J. Neeson

    Published in Haematologica (2022-06-01)
    Get full text
    Article


  13. 13

    TIRE-seq simplifies transcriptomics via integrated RNA capture and library preparation by Piper O’Keeffe, Yasmin Nouri, Hui Shi Saw, Zachery Moore, Tracey M. Baldwin, Sam W. Z. Olechnowicz, Jafar S. Jabbari, David McG Squire, Stephen Leslie, Changqing Wang, Yupei You, Matthew E. Ritchie, Ryan S. Cross, Misty R. Jenkins, Cindy Audiger, Shalin H. Naik, James R. Whittle, Saskia Freytag, Sarah A. Best, Peter F. Hickey, Daniela Amann-Zalcenstein, Rory Bowden, Daniel V. Brown

    Published in Scientific Reports (2025-05-01)
    Get full text
    Article


Search Tools: